openPR Logo
Press release

BRIC Gastric Bands and Balloons Market to Reach USD 1.5 Billion by 2034

09-24-2025 12:04 PM CET | Health & Medicine

Press release from: Exactitude Consultancy

BRIC Gastric Bands and Balloon

BRIC Gastric Bands and Balloon

Gastric bands and balloons are minimally invasive weight loss devices used to aid in weight reduction for individuals suffering from obesity or those looking for an effective alternative to surgical weight loss procedures. These devices function by restricting stomach capacity, leading to early satiety and reduced food intake. Gastric bands, typically adjustable, are surgically placed around the stomach, while gastric balloons are inserted endoscopically and inflated to limit stomach space.

Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72333

The BRIC (Brazil, Russia, India, and China) countries represent a high-growth market for gastric bands and balloons, driven by increasing obesity rates, the growing demand for non-surgical weight loss options, and improvements in healthcare access. Technological advancements in gastric balloon formulations and adjustable band systems are further propelling the market, offering better patient outcomes and reduced recovery times compared to traditional weight loss surgeries.

Market Overview
• Market Size (2024): USD 0.6 billion
• Forecast (2034): USD 1.5 billion
• CAGR (2025-2034): 9.4%

Key Highlights:
• Obesity is the primary driver of market growth, with BRIC countries witnessing a significant increase in weight loss treatments.
• Non-surgical weight loss solutions, particularly gastric balloons, are becoming popular due to their minimally invasive nature and shorter recovery times.
• Increasing access to affordable healthcare, government initiatives, and growing awareness about obesity-related health risks are key contributors to market growth.
• China and India are expected to see the highest demand growth due to rising obesity rates and improving healthcare infrastructure.

Segmentation Analysis
By Device Type:
• Gastric Bands
o Adjustable Gastric Bands (AGB) are placed around the stomach to reduce its size, leading to reduced food intake and increased satiety.
o The most commonly used gastric bands include the Lap-Band and Realize Band, which can be adjusted to change the restriction level.
• Gastric Balloons
o Intragastric balloons are inserted endoscopically and inflated to occupy space in the stomach, reducing the amount of food the stomach can hold.
o Single Balloon and Dual Balloon systems, such as Orbera and ReShape, are the most common types.
o Adjustable balloons offer flexibility in volume adjustments for optimal patient comfort and treatment outcomes.

By Application:
• Obesity Management
o The dominant application for gastric bands and balloons is weight loss in morbidly obese individuals or those with a BMI ≥30.
o Gastric balloons are often used for short-term weight loss, especially in patients with a BMI ≥30 to 40.
• Weight Loss for Health Conditions
o Used for managing obesity-related diseases such as type 2 diabetes, hypertension, and sleep apnea.
• Cosmetic and Aesthetic Weight Loss
o Increasing demand from individuals seeking non-invasive options to achieve cosmetic weight loss.

By End Use:
• Hospitals & Surgical Centers
o Gastric bands and balloons are primarily used in hospital settings and weight loss clinics where specialized procedures are performed.
• Ambulatory Surgical Centers (ASCs)
o Minimally invasive procedures such as gastric balloon insertions are increasingly being performed in ASCs due to cost-effectiveness and faster recovery.
• Private Weight Loss Clinics
o The rise of specialized clinics focusing on non-surgical weight loss treatments has significantly increased the adoption of gastric bands and balloons.
• Retail & Online Pharmacies
o As consumer awareness grows, non-surgical weight loss products are becoming more available for over-the-counter purchase.

Segmentation Summary:
Gastric balloons are seeing increasing adoption due to their non-surgical, minimally invasive nature, while gastric bands remain widely used in restrictive weight loss surgeries. The obesity management segment continues to be the largest, but cosmetic weight loss applications are emerging as a significant growth opportunity.

Explore Full Report here: https://exactitudeconsultancy.com/reports/72333/bric-gastric-bands-and-balloons-market

Regional Analysis
China
• The largest market in Asia-Pacific, driven by rising obesity rates, increasing healthcare access, and the growing popularity of minimally invasive treatments.
• The market is expected to expand rapidly due to the increased demand for bariatric procedures and non-surgical weight loss devices.
India
• India has a growing demand for affordable weight loss treatments, particularly gastric balloons for short-term weight loss.
• Government-led healthcare reforms and increased access to weight loss solutions in urban and tier-2 cities are fueling market growth.
Brazil
• Brazil is the largest market in Latin America, with obesity becoming a growing concern, and gastric bands and balloons becoming more commonly used for non-surgical weight loss.
• Increased awareness of minimally invasive procedures and affordable healthcare options will drive future market growth.
Russia
• Russia is witnessing a rise in the prevalence of obesity and diabetes, leading to an increasing demand for non-surgical weight loss solutions.
• Private healthcare facilities are growing, with an increase in gastric band and balloon treatments.
South Africa
• The demand for gastric balloons is increasing, especially in urban areas, where non-invasive weight loss options are becoming more accepted.
Regional Summary:
China and India will drive the largest growth in the BRIC gastric bands and balloons market due to increasing obesity rates, improving healthcare access, and rising demand for non-surgical weight loss solutions. Brazil follows closely, with Russia showing promising growth in non-invasive weight loss treatments.

Market Dynamics
Key Growth Drivers:
• Rising prevalence of obesity and associated health issues, such as type 2 diabetes, cardiovascular diseases, and hypertension.
• Minimally invasive techniques are gaining popularity due to their short recovery times and reduced complications compared to traditional weight loss surgeries.
• Technological advancements in gastric balloon formulations, including adjustable balloons and longer-lasting devices.
• Increasing demand for cosmetic weight loss solutions in urban areas and rising consumer awareness.
• Government healthcare initiatives and private insurance coverage for obesity treatments in BRIC countries.

Key Challenges:
• High cost of gastric band and gastric balloon treatments, which may limit access in low-income regions.
• Complications associated with gastric balloon insertions (e.g., nausea, discomfort) and gastric band adjustments.
• Regulatory approval processes for new gastric balloon devices and the lack of standardization in some markets.

Latest Trends:
• Combination therapies that integrate gastric balloons with dietary counseling and lifestyle changes to enhance long-term weight loss.
• Smart gastric balloons integrated with digital health tools for patient monitoring and personalized weight loss plans.
• Growth of robot-assisted balloon placement systems offering greater precision and less invasive procedures.
• Affordable non-surgical weight loss solutions gaining popularity in developing countries due to rising healthcare access and increased focus on obesity management.

Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72333

Competitor Analysis
Major Players in the Market:
• Apollo Endosurgery (ORBERA Gastric Balloon, ReShape)
• Allergan Inc. (Lap-Band)
• ReShape Lifesciences (ReShape Balloon)
• EndoBiome (Stabilized Gastric Balloons)
• Medtronic PLC (Mini Gastric Bypass Devices)
• BaroNova (Endoscopic Weight Loss Devices)
• Häagen-Dazs (Gastric Banding Systems)
• Spatz Medical (Adjustable Gastric Balloons)

Competitive Summary:
Apollo Endosurgery and Allergan dominate the gastric balloon market, while Medtronic and ReShape Lifesciences provide a mix of adjustable band and gastric balloon systems. Spatz Medical is gaining ground with its adjustable balloon solutions for more customized weight loss treatments. The market is highly competitive with emerging trends in robot-assisted procedures and digital health monitoring integrated with gastric balloons.

Conclusion
The BRIC Gastric Bands and Balloons Market, valued at USD 0.6 billion in 2024, is projected to reach USD 1.5 billion by 2034, growing at a CAGR of 9.4%.

Key Takeaways:
• Gastric balloons are increasingly popular due to their minimally invasive nature, while gastric bands continue to dominate for restrictive weight loss surgeries.
• Obesity management is the largest application area, but cosmetic weight loss is emerging as a key growth segment.
• China and India will experience the highest growth in demand, followed by Brazil and Russia.
• Technological advancements in adjustable balloons and robot-assisted procedures will continue to drive the market.

The BRIC gastric bands and balloons market is set for continued growth, supported by innovations in weight loss technologies, increasing access to minimally invasive procedures, and rising demand for affordable non-surgical weight loss solutions.

This report is also available in the following languages : Japanese (BRIC 胃バンドおよびバルーン市場), Korean (BRIC 위밴드 및 풍선 시장), Chinese (金砖四国胃束带和胃球囊市场), French (Marché des anneaux et ballons gastriques BRIC), German (BRIC-Markt für Magenbänder und Ballons), and Italian (Mercato dei nastri e dei palloncini gastrici BRIC), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/reports/72333/bric-gastric-bands-and-balloons-market#request-a-sample

Our More Reports:

China Biologics Contract Manufacturing Market
https://exactitudeconsultancy.com/reports/72916/china-biologics-contract-manufacturing-market

Cell Reprogramming Market
https://exactitudeconsultancy.com/reports/72917/cell-reprogramming-market

Blood Brain Barrier Market
https://exactitudeconsultancy.com/reports/72918/blood-brain-barrier-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release BRIC Gastric Bands and Balloons Market to Reach USD 1.5 Billion by 2034 here

News-ID: 4195717 • Views:

More Releases from Exactitude Consultancy

BRIC Reconstruction Meshes Market to Hit USD 2.0 Billion by 2034
BRIC Reconstruction Meshes Market to Hit USD 2.0 Billion by 2034
Reconstruction meshes play a vital role in surgical procedures involving the repair of tissue defects, especially in hernia repairs, abdominal wall reconstruction, and breast reconstruction. These devices provide structural support to the repaired tissue, reinforce weak areas, and help to prevent complications such as hernia recurrence or wound dehiscence. Reconstruction meshes are made from synthetic materials like polypropylene, polyester, and PTFE, or biological materials like collagen and porcine-derived products, depending
Asia-Pacific Robotic Surgery Market to Hit USD 9.2 Billion by 2034
Asia-Pacific Robotic Surgery Market to Hit USD 9.2 Billion by 2034
Robotic surgery is revolutionizing the field of surgical procedures by offering increased precision, control, and flexibility. These systems allow surgeons to perform complex procedures with minimal incisions, leading to shorter recovery times, reduced complication rates, and improved patient outcomes. Robotic-assisted surgeries are increasingly adopted across various specialties such as orthopedics, urology, gynecology, and cardiac surgery. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72335 The Asia-Pacific robotic surgery market is experiencing
BRIC Robotic Surgery Market Set to Reach USD 4.3 Billion by 2034
BRIC Robotic Surgery Market Set to Reach USD 4.3 Billion by 2034
Robotic surgery, an advanced form of minimally invasive surgery, uses robotic systems to assist surgeons in performing complex surgical procedures with greater precision, control, and flexibility. These systems enhance a surgeon's ability to perform delicate and intricate procedures while minimizing patient trauma, reducing recovery time, and improving overall outcomes. With applications in a variety of specialties such as orthopedics, urology, gynecology, cardiac surgery, and general surgery, robotic systems are transforming
BRIC Embolization Particles Market to Reach USD 3.8 Billion by 2034
BRIC Embolization Particles Market to Reach USD 3.8 Billion by 2034
Embolization therapy is a crucial minimally invasive procedure used to treat a variety of conditions, including tumors, vascular malformations, bleeding control, and uterine fibroids. The therapy involves using embolic agents, such as embolization particles, which are introduced into blood vessels to block or reduce blood flow to target areas. Embolization particles can be made of polymeric materials, microspheres, or gel-based particles, offering targeted and controlled blockage for effective treatments. Download Full

All 5 Releases


More Releases for Gastric

Rising Gastric Cancer Cases Fuel Growth In Gastric Cancer Drugs Market Driving M …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Gastric Cancer Drugs Market Size By 2025? In recent times, the market size for gastric cancer drugs has seen a swift expansion. Projections forecast growth from $4.41 billion in 2024 to $4.9 billion in 2025, a compound annual growth rate (CAGR) of 11.2%. Factors contributing
Increasing Geriatric Population Fuels Gastric Ulcers Market Growth Driving Marke …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Gastric Ulcers Market Size By 2025? In the last few years, the market size for gastric ulcers has been expanding notably. It is anticipated to increase from $4.29 billion in 2024 to $4.54 billion in 2025, boasting a compound annual growth rate (CAGR) of 5.9%.
Increasing Geriatric Population Fuels Gastric Ulcers Market Growth Driver: Leadi …
How Are the key drivers contributing to the expansion of the gastric ulcers market? The rising geriatric population is expected to accelerate the growth of the gastric ulcers market. The geriatric population, typically individuals aged 65 and above, is growing due to improvements in healthcare and increased life expectancy. This population is more susceptible to gastric ulcers due to factors like the use of NSAIDs and decreased mucosal protection. For instance,
Top Factor Driving Gastric Cancer Drugs Market Growth in 2025: Rising Gastric Ca …
What market dynamics are playing a key role in accelerating the growth of the gastric cancer drugs market? The rise in obesity and smoking rates has led to an increased prevalence of gastric cancer. Factors like tobacco use and poor dietary habits have been linked to a higher risk of developing this disease. As per data from the Government Digital Service in the UK, it was projected in May 2023 that
Gastric Cancer Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Gastric Cancer Pipeline Insight 2024" report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in Gastric Cancer pipeline landscape. It covers the pipeline drug profiles, including Gastric Cancer clinical trials and nonclinical stage products. It also covers the Gastric Cancer therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Key Takeaways from the Gastric Cancer
Gastric Function Test Market - Empowering Digestive Health: Gastric Function Tes …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Gastric Function Test Market. Gastric Function Test Market: https://www.growthplusreports.com/report/gastric-function-test-market/9126 The Gastric Function Test Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the